Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 6, 2002, Pages 1379-1381

  Chutkowski, Christine ^a   Olson, Betty ^a   McDonough, Ann ^a   Mahoney, James ^a   McSharry, James J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FLUOROCHROME; MONOCLONAL ANTIBODY;

ARTICLE; DOSE RESPONSE; DRUG SENSITIVITY; FLOW CYTOMETRY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; PRIORITY JOURNAL;

ACYCLOVIR; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; FLOW CYTOMETRY; FLUORESCENT DYES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0036844187     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.6.1379-1381.2002     Document Type: Article

References (25)

1. Armstrong, G. L., J. Schillinger, L. Markowitz, A. J. Nahmias, R. E. Johnson, G. M. McQuillan, and M. E. St. Louis. 2001. Incidence of herpes simplex virus type 2 infection in the United States. Am. J. Epidemiol. 153:912-920.
2. Cassidy, K. A., and R. J. Whitley. 1997. New therapeutic approaches to the alphaherpesvirus infections. J. Antimicrob. Chemother. 39:119-128.
3. Christophers, J., J. Clayton, J. Craske, R. Ward, P. Collins, M. Trowbridge, and G. Darby. 1998. Survey of resistance of herpes simplex virus to acyclovir in Northwest England. Antimicrob. Agents Chemother. 42:868-872.
4. Darby, G., H. J. Field, and S.A. Salisbury. 1981. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature 289:81-83.
5. Darville, J. M., B. E. Ley, A. F. Roome, and A. B. Foot. 1998. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population. Bone Marrow Transplant. 22:587-589.
6. De La Iglesia, P., S. Melon, B. Lopez, M. Rodriguez, M. I. Blanco, P. Mellado, and M. de Ona. 1998. Rapid screening tests for determining in vitro susceptibility of herpes simplex virus clinical isolates. J. Clin. Microbiol. 36:2389-2391.
7. Field, A. K., and K. K. Biron. 1994. "The end of innocence" revisited: Resistance of herpesviruses to antiviral drugs. Clin. Microbiol. Rev. 7:1-13.
8. Gaudreau, A., E. Hill, H. H. Balfour, Jr., A. Erice, and G. Boivin. 1998. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178:297-303.
9. Javaly, K., M. Wohlfeiler, K. R. Klein, Y. Bryson, K. Grafford, S. Martin-Munely, and W. D. Hardy. 1999. Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: A phase 1/11 study. J. Acquir. Immune Defic. Syndr. 21:301-306.
10. Jofre, J. T., P. A. Schaffer, and D. A. Parris. 1977. Genetics of resistance to phosphonoacetic acid in strain KOS of herpes simplex virus type 1. J. Virol. 23:833-836.
11. Kost, R., E. L. Hill, M. Tigges, and S. E. Straus. 1993. Recurrent acyclovir resistant genital herpes in an immunocompetent patient. N. Engl. J. Med. 329:1777-1782.
12. McLaren, C., M. N. Ellis, and G. A. Hunter. 1983. A colorimetric assay for measurement of the sensitivity of herpes simplex virus to antiviral agents. Antivir. Res. 3:223-234.
13. McSharry, J. J., R. Costantino, M. B. McSharry, R. A. Venezia, and J. M. Lehman. 1990. Rapid detection of herpes simplex virus in clinical samptes by flow cytometry after amplification in tissue culture. J. Clin. Microbiol. 28:1864-1866.
14. McSharry, J. J., N. S. Lurain, G. L. Drusano, A. Landay, J. Manischewitz, M. Nokta, M. O'Gorman, H. M. Shapiro, A. Weinberg, P. S. Reichelderfer, and C. S. Crumpacker. 1998. Flow cytometric determination of ganciclovir susceptibility of human cytomegalovirus clinical isolates. J. Clin. Microbiol. 36:958-964.
15. McSharry, J. J., N. S. Lurain, G. L. Drusano, A. Landay, M. Nokta, M. O'Gorman, A. Weinberg, H. M. Shapiro, P. S. Reichelderfer, and C. S. Crumpacker. 1998. Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. Antimicrob. Agents Chemother. 42:2326-2331.
16. McSharry, J. J. 1999. Antiviral drug susceptibility assays: Going with the flow. Antivir. Res. 43:1-21.
17. Oram, R. J., D. Marcellino, D. Strauss, E. Gustafson, C. L. Talarico, A. K. Root, P. L. Sharma, K. Thompson, J. D. Fingeroth, C. Crumpacker, and B. C. Harold. 2000. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J. Infect. Dis. 181:1458-1461.
18. Pavic, I., A. Hartmann, A. Zimmermann, D. Michel, W. Hampl, I. Schleher, and T. Mertens. 1997. Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. Antimicrob. Agents Chemother. 41:2686-2692.
19. Safrin, S., T. Elbeik, L. Phan, D. Robinson, J. Rush, A. Elbaggari, and J. Mills. 1994. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 38:1246-1250.
20. Safrin, S., T. Elbeik, and J. Mills. 1994. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. J. Infect. Dis. 169:879-882.
21. Sibrach, C. D., L. T. Gutman, C. M. Wilfert, C. McLaren, M. H. St. Clair, P. M. Keller, and D. W. Barry. 1982. Pathogenicity of acyclovir resistant herpes simplex virus type 1 from an immunodeficient child. J. Infect. Dis. 146:673-682.
22. Stanberry, L., A. Cunningham, G. Mertz, A. Mindel, B. Peters, M. Reitano, S. Sacks, A. Wald, S. Wassilew, and P. Woolley. 1999. New developments in the epidemiology, natural history, and management of genital herpes. Antivir. Res. 42:1-14.
23. Swierkosz, E. M., D. R. Scholl, J. L. Brown, J. D. Jollick, and C. A. Gleaves. 1987. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob. Agents Chemother. 31:1465-1469.
24. Tebas, P., E. C. Stabell, and P. Olivo. 1995. Antiviral susceptibility testing with a cell line which expresses β-galactosidase after infection with herpes simplex virus. Antimicrob. Agents Chemother. 39:1287-1291.
25. Whitley, R. J., D. W. Kimberlin, and B. Roizman. 1998. Herpes simplex viruses. Clin. Infect. Dis. 26:541-555.